This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Healthcare ETFs in Focus Ahead of Q4 Earnings
by Sweta Killa
With lower negative earnings revisions, the healthcare sector is expected to witness earnings growth of 7.7% in the fourth quarter, suggesting continued outperformance for healthcare ETFs.
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus
by Sweta Killa
Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.
UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy
by Sweta Killa
ETFs having the largest allocation to UnitedHealth has been in focus post its solid result.
Top-Ranked Sector ETFs & Stocks to Buy for 2019
by Sweta Killa
Investors could be well served by ETFs and stocks from top-ranked sectors.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
Best Sector of 2018 and its Hit ETFs & Stocks
by Sweta Killa
Healthcare was the best-performing sector of 2018 and we have highlighted top-performing ETFs and stocks from this sector.
10 Top-Ranked ETFs That Crushed the Market in 2018
by Sweta Killa
While there have been losers in most corner of the space, several ETFs still managed to end the year in green and are likely to continue outperforming in 2019 too.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Trump's Presidential 2 Years: Must-See ETF Areas
by Sanghamitra Saha
Inside the ETF areas that were most talked-about in the Trump presidency.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Healthcare ETFs to Buy Ahead of Q3 Earnings
by Sweta Killa
The positive estimate revisions suggest continued outperformance for the healthcare ETFs.
Top-Ranked Healthcare ETFs for Long-Term Investors
by Neena Mishra
Healthcare is now the best-performing sector of 2018. We highlight two top-ranked ETFs suitable for long-term investors.
3 Globally Winning ETF Areas of Q3
by Sanghamitra Saha
Inside the winning ETF areas of the third quarter.
Top Performing ETFs of the Third Quarter
by Neena Mishra
Healthcare emerged as the new leader in Q3. Here is what investors need to know about best performing sectors and ETFs.
Q3 ETF Asset Flow Roundup: What's Hot & What's Not
by Sweta Killa
We have highlighted several zones and their ETFs that have garnered enough investors' interest while few that have shunned by investors.
Fed Hikes Rates as Expected: ETF Areas That Gained
by Sanghamitra Saha
The Fed hikes rates as expected and there was no wild movement in the market. These ETF areas ended in the green post hike.
5 Health Care ETFs Outperforming XLV on YTD Basis
by Zacks Equity Research
Health care ETFs provide handsome returns year to date.
4 Sector ETFs Brimming With Inflows
by Sanghamitra Saha
If some sector ETFs attracted investors' attention past months, those were all defensive.
Health Care ETFs Outperforming: Will the Rally Last?
by Sanghamitra Saha
Health care ETFs are defensive ones, which helped those to shine amid market doldrums.
ETF Asset Report of July
by Sanghamitra Saha
Inside the ETFs what amassed solid assets and the ones that lost the most.
Healthcare ETFs to Buy on Solid Q2 Earnings Expectations
by Sweta Killa
With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 9.1% in the second quarter, suggesting continued outperformance for healthcare ETFs.
Healthcare ETFs to Ride on UnitedHealth's Solid Q2 & Outlook
by Sweta Killa
Investors should tap the opportunity with ETFs having the largest allocation to UnitedHealth.
Healthcare ETFs in Focus Following JNJ Q2 Results
by Sweta Killa
Investors should closely watch the movement of the Johnson & Johnson and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.